CEP-751 inhibits trk receptor tyrosine kinase activityin vitro and exhibits anti-tumor activityAnna Marie Camoratto, Craig A. Dionne, Nicola T. Neff et al.|International Journal of Cancer|1997Cited by 76
SAR and chemistry of Aurora kinase inhibitors: Discovery of PF-3814735, an oral clinical candidateSamit K. Bhattacharya, Xumiao Zhao, Donn G. Wishka et al.|Cancer Research|2008Cited by 5
CEP‐751 inhibits trk receptor tyrosine kinase activity in vitro and exhibits anti‐tumor activityAnna Marie Camoratto, Craig A. Dionne, Jitesh P. Jani et al.|International Journal of Cancer|1997Cited by 0